Ciprofibrate
CAY-18515-1 1 g
Data Sheet: 
CAS
52214-84-3
Formulation
A crystalline solid
Purity
≥98%
MW
289,2
Shipment
-20
Long Term Storage
-20
Description
An agonist of PPARα (EC50 = 0.9 µM in a transactivation assay); selective for PPARα over PPARγ and PPARδ at 300 µM; induces cell cycle arrest at the G2/M and S phases in Fao, but not HepG2, cells at 250 µM; decreases fasting plasma levels of triglycerides and increases fasting plasma glucose levels in the apolipoprotein CIII transgenic mouse model of hypertriglyceridemia at 10 mg/kg
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
